TESARO ROA 2011-2018 | TSRO

Current and historical return on assets (ROA) values for TESARO (TSRO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. TESARO ROA for the three months ending September 30, 2018 was -83.34%.
TESARO ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.65B $0.71B -83.39%
2018-06-30 $-0.54B $0.81B -69.56%
2018-03-31 $-0.52B $0.73B -71.43%
2017-12-31 $-0.50B $0.86B -67.16%
2017-09-30 $-0.45B $0.69B -61.35%
2017-06-30 $-0.51B $0.65B -69.84%
2017-03-31 $-0.42B $0.76B -63.42%
2016-12-31 $-0.37B $0.84B -67.03%
2016-09-30 $-0.31B $0.69B -75.38%
2016-06-30 $-0.29B $0.36B -91.02%
2016-03-31 $-0.29B $0.34B -91.15%
2015-12-31 $-0.25B $0.26B -74.33%
2015-09-30 $-0.23B $0.32B -66.91%
2015-06-30 $-0.19B $0.36B -58.21%
2015-03-31 $-0.17B $0.41B -60.39%
2014-12-31 $-0.17B $0.26B -75.58%
2014-09-30 $-0.15B $0.30B -74.78%
2014-06-30 $-0.14B $0.16B -87.28%
2014-03-31 $-0.12B $0.19B -74.92%
2013-12-31 $-0.09B $0.14B -54.95%
2013-09-30 $-0.09B $0.16B -53.29%
2013-06-30 $-0.07B $0.18B -45.54%
2013-03-31 $-0.07B $0.20B -46.83%
2012-12-31 $-0.06B $0.13B -59.90%
2012-09-30 $-0.04B $0.14B -59.93%
2012-06-30 $-0.03B $0.15B -87.67%
2012-03-31 $-0.01B $0.00B inf%
2011-12-31 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.027B $0.223B
Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.375B 11.43
Zoetis (ZTS) United States $43.289B 29.64
Grifols (GRFS) Spain $14.701B 17.94
Tilray (TLRY) United States $9.945B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.637B 12.40
Neurocrine Biosciences (NBIX) United States $7.919B 1746.60
Ionis Pharmaceuticals (IONS) United States $7.377B 0.00
Nektar Therapeutics (NKTR) United States $6.579B 9.43
Impax Laboratories (AMRX) United States $5.589B 29.71
Catalent (CTLT) United States $5.483B 23.00
Sage Therapeutics (SAGE) United States $5.144B 0.00
United Therapeutics (UTHR) United States $5.079B 8.31
Loxo Oncology (LOXO) United States $4.598B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.943B 14.60
FibroGen (FGEN) United States $3.332B 0.00
USANA Health Sciences (USNA) United States $2.876B 24.48
Endo (ENDP) Ireland $2.795B 4.28
Xencor (XNCR) United States $2.152B 0.00
Aerie Pharmaceuticals (AERI) United States $1.980B 0.00
Endocyte (ECYT) United States $1.939B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.895B 256.00
Heron Therapeutics (HRTX) United States $1.876B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.855B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.843B 0.00
Zogenix (ZGNX) United States $1.690B 0.00
PTC Therapeutics (PTCT) United States $1.654B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.516B 18.55
Theravance Biopharma (TBPH) Cayman Islands $1.453B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.398B 0.00
Corcept Therapeutics (CORT) United States $1.396B 20.49
Portola Pharmaceuticals (PTLA) United States $1.285B 0.00
Esperion Therapeutics (ESPR) United States $1.264B 0.00
Tricida (TCDA) United States $1.234B 0.00
TherapeuticsMD (TXMD) United States $1.125B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.075B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.900B 0.00
ImmunoGen (IMGN) United States $0.826B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.720B 0.00
Radius Health (RDUS) United States $0.706B 0.00
Karyopharm Therapeutics (KPTI) United States $0.648B 0.00
Flexion Therapeutics (FLXN) United States $0.605B 0.00
Collegium Pharmaceutical (COLL) United States $0.565B 0.00
GlycoMimetics (GLYC) United States $0.498B 0.00
ChemoCentryx (CCXI) United States $0.477B 37.80
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.473B 0.00
Siga Technologies (SIGA) United States $0.453B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.445B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 25.06
Dova Pharmaceuticals (DOVA) United States $0.423B 0.00
Odonate Therapeutics (ODT) United States $0.421B 0.00
Xeris Pharmaceuticals (XERS) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.416B 0.00
Dermira (DERM) United States $0.409B 0.00
OptiNose (OPTN) United States $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.408B 0.00
ArQule (ARQL) United States $0.402B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.395B 0.00
Forty Seven (FTSV) United States $0.395B 0.00
Aclaris Therapeutics (ACRS) United States $0.359B 0.00
CASI Pharmaceuticals (CASI) United States $0.357B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Depomed (ASRT) United States $0.345B 12.83
Zafgen (ZFGN) United States $0.344B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.341B 0.00
KalVista Pharmaceuticals (KALV) United States $0.338B 0.00
Minerva Neurosciences (NERV) United States $0.324B 0.00
Aratana Therapeutics (PETX) United States $0.316B 0.00
Mast Therapeutics (SVRA) United States $0.315B 0.00
Translate Bio (TBIO) United States $0.309B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Tapimmune (MRKR) United States $0.301B 0.00
Affimed (AFMD) Germany $0.274B 0.00
Majesco Entertainment (PTE) United States $0.267B 0.00
IMV INC (IMV) Canada $0.248B 0.00
Lannett Co Inc (LCI) United States $0.241B 2.11
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Tyme Technologies (TYME) United States $0.227B 0.00
Opexa Therapeutics (ACER) United States $0.221B 0.00
Ocular Therapeutix (OCUL) United States $0.215B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.200B 0.00
MEI Pharma (MEIP) United States $0.194B 0.00
Calithera Biosciences (CALA) United States $0.189B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.189B 0.00
ElectroCore (ECOR) United States $0.182B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.181B 0.00
Neon Therapeutics (NTGN) United States $0.178B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.178B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.177B 0.00
Ardelyx (ARDX) United States $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 0.00
Molecular Templates (MTEM) United States $0.169B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Redhill Biopharma (RDHL) Israel $0.160B 0.00
MediWound (MDWD) Israel $0.157B 0.00
Jounce Therapeutics (JNCE) United States $0.150B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.148B 0.00
Melinta Therapeutics (MLNT) United States $0.146B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
DURECT (DRRX) United States $0.138B 0.00
Adherex Technologies (FENC) United States $0.132B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.114B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.109B 0.00
Rafael Holdings (RFL) United States $0.108B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.099B 0.00
CTI BioPharma (CTIC) United States $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.093B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.089B 0.00
Achaogen (AKAO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.075B 0.00
Natural Alternatives (NAII) United States $0.074B 7.25
Otonomy (OTIC) United States $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.070B 0.00
BioLineRx (BLRX) Israel $0.068B 0.00
KemPharm (KMPH) United States $0.068B 0.00
Immune Design (IMDZ) United States $0.065B 0.00
Forward Pharma (FWP) Denmark $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.061B 0.00
Novan (NOVN) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 35.79
Neos Therapeutics (NEOS) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
Trillium Therapeutics (TRIL) Canada $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.87
Lipocine (LPCN) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
ESSA Pharma (EPIX) Canada $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.35
Shineco (TYHT) China $0.016B 1.61
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
PharmAthene (ALT) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00